Witcher; Derrick Ryan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Witcher; Derrick Ryan.The latest application filed is for "cd200r agonist antibodies and uses thereof".
Company Profile
1.19.29
- Witcher; Derrick Ryan - Fishers IN
Patent Activity
| Patent | Date |
|---|---|
| Cd200r Agonist Antibodies And Uses Thereof App 20220251198 - Demarest; Stephen J. ; et al. | 2022-08-11 |
| CD200R agonist antibodies and uses thereof Grant 11,319,370 - Demarest , et al. May 3, 2 | 2022-05-03 |
| Pan-elr+ Cxc Chemokine Antibodies For The Treatment Of Hidradenitis Suppurativa App 20210340244 - Kikly; Kristine Kay ; et al. | 2021-11-04 |
| Pan-ELR+ CXC chemokine antibodies Grant 10,858,425 - Beidler , et al. December 8, 2 | 2020-12-08 |
| Cd200r Agonist Antibodies And Uses Thereof App 20200087395 - Demarest; Stephen J ; et al. | 2020-03-19 |
| Pan-ELR+ CXC CHEMOKINE ANTIBODIES App 20180362631 - Beidler; Catherine Brautigam ; et al. | 2018-12-20 |
| Pan-ELR+ CXC chemokine antibodies Grant 10,093,727 - Beidler , et al. October 9, 2 | 2018-10-09 |
| Anti-CD20- / anti-BAFF bispecific antibodies Grant 9,951,146 - Allan , et al. April 24, 2 | 2018-04-24 |
| Pan-ELR+ CXC CHEMOKINE ANTIBODIES App 20170362315 - Beidler; Catherine Brautigam ; et al. | 2017-12-21 |
| Pan-ELR.sup.+ CXC chemokine antibodies Grant 9,783,605 - Beidler , et al. October 10, 2 | 2017-10-10 |
| Anti-cd20- / Anti-baff Bispecific Antibodies App 20160289342 - Allan; Barrett ; et al. | 2016-10-06 |
| Anti-TNF-anti-IL-17 bispecific antibodies Grant 9,416,182 - Allan , et al. August 16, 2 | 2016-08-16 |
| Pan-elr+ Cxc Chemokine Antibodies App 20160152699 - Beidler; Catherine Brautigam ; et al. | 2016-06-02 |
| Pan-ELR+ CXC Chemokine Antibodies Grant 9,290,570 - Beidler , et al. March 22, 2 | 2016-03-22 |
| Pan-ELR+ CXC CHEMOKINE ANTIBODIES App 20140271647 - Beidler; Catherine Brautigam ; et al. | 2014-09-18 |
| Anti-tnf-anti-il-17 Bispecific Antibodies App 20140255406 - Allan; Barrett ; et al. | 2014-09-11 |
| Anti-hepcidin antibodies and uses thereof Grant 8,765,129 - Leung , et al. July 1, 2 | 2014-07-01 |
| Anti-ferroportin 1 monoclonal antibodies and uses thereof Grant 8,679,497 - Leung , et al. March 25, 2 | 2014-03-25 |
| Anti-hepcidin-25 selective antibodies and uses thereof Grant 8,609,817 - Leung , et al. December 17, 2 | 2013-12-17 |
| Anti-hepcidin Antibodies And Uses Thereof App 20130164304 - Leung; Donmienne Doen Mun ; et al. | 2013-06-27 |
| Anti-ferroportin 1 Monoclonal Antibodies And Uses Thereof App 20130122013 - LEUNG; Donmienne Doen Mun ; et al. | 2013-05-16 |
| Anti-hepcidin antibodies and uses thereof Grant 8,329,174 - Leung , et al. December 11, 2 | 2012-12-11 |
| Anti-ferroportin 1 monoclonal antibodies and uses thereof Grant 8,183,346 - Leung , et al. May 22, 2 | 2012-05-22 |
| Anti-ferroportin 1 Monoclonal Antibodies And Uses Thereof App 20120100148 - Leung; Donmienne Doen Mun ; et al. | 2012-04-26 |
| Anti-hepcidin-25 Selective Antibodies And Uses Thereof App 20110189190 - Leung; Donmienne Doen Mun ; et al. | 2011-08-04 |
| Anti-ferroportin 1 Monoclonal Antibodies And Uses Thereof App 20110129480 - Leung; Donmienne Doen Mun ; et al. | 2011-06-02 |
| Humanized anti-ghrelin antibodies Grant 7,901,679 - Marquis , et al. March 8, 2 | 2011-03-08 |
| Anti-hepcidin Antibodies And Uses Thereof App 20110027261 - Leung; Donmienne Doen Mun ; et al. | 2011-02-03 |
| Anti-hepcidin antibodies and uses thereof Grant 7,820,163 - Leung , et al. October 26, 2 | 2010-10-26 |
| Humanized Anti-ghrelin Antibodies App 20090181018 - Marquis; David Matthew ; et al. | 2009-07-16 |
| Anti-hepcidin Antibodies And Uses Thereof App 20090136495 - Gately; Dennis Patrick ; et al. | 2009-05-28 |
| Desacyl Ghrelin Antibodies And Therapeutic Uses Thereof App 20090060920 - Witcher; Derrick Ryan ; et al. | 2009-03-05 |
| Humanized anti-ghrelin antibodies Grant 7,479,271 - Marquis , et al. January 20, 2 | 2009-01-20 |
| Antagonistic Anti-hTNFSF13b Human Antibodies App 20080175841 - Gelfanova; Valentina Pavlovna ; et al. | 2008-07-24 |
| Humanized Anti-Ghrelin Antibodies App 20080118498 - Marquis; David Matthew ; et al. | 2008-05-22 |
| Anti-Ghrelin Antibodies App 20070237775 - Kikly; Kristine Kay ; et al. | 2007-10-11 |
| Erythropoietic compounds App 20070100133 - Beals; John Michael ; et al. | 2007-05-03 |
| Anti-ghrelin antibodies App 20060233788 - Heiman; Mark Louis ; et al. | 2006-10-19 |
| Flint polypeptide analogs Grant 6,965,012 - Becker , et al. November 15, 2 | 2005-11-15 |
| Anti-interleukin-1 beta analogs App 20050070692 - Beals, John Michael ; et al. | 2005-03-31 |
| Antagonistic anti-htnfsf13b human antibodies App 20050070694 - Gelfanova, Valentina Pavlovna ; et al. | 2005-03-31 |
| Protease resistant flint analogs Grant 6,835,814 - Micanovic , et al. December 28, 2 | 2004-12-28 |
| Flint glycoforms App 20040176279 - Jenkins, Nigel ; et al. | 2004-09-09 |
| Treating musculoskeletal disorders using lp85 and analogs thereof App 20030100502 - Beals, John Michael ; et al. | 2003-05-29 |
| Stability of flint through o-linked glycosylation App 20030055221 - Lu, Jirong ; et al. | 2003-03-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 